Cancer HealthCast: NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
Modernizing Data for Operational Efficiency
USPS, NIH and Pure Storage discuss their data modernization strategies to prepare for artificial intelligence.
36m watch -
Accelerating Software Modernization in Defense
The Defense Department modernizes software to enhance national security with agile development, DevSecOps and emerging tech like AI and quantum computing.
15m read -
White House Releases New Memos on AI Acquisition, Innovation
The White House unveiled new guidance on AI acquisition and innovation since replacing the Biden-era executive order earlier this year.
4m read -
Cyber Leaders Call for 'Data Dominance' to Drive Compliance
Officials emphasize how data dominance and sharing best practices help agencies meet critical cyber compliance goals.
4m read
